Jorge Emilio Jalil Milad

Title: Innovations in Hypertension Treatment by Jorge Emilio Jalil Milad

Introduction

Jorge Emilio Jalil Milad is a prominent inventor based in Santiago, Chile. He has made significant contributions to the field of medicine, particularly in the treatment of hypertension. With a total of 2 patents, his work focuses on innovative approaches to managing cardiovascular health.

Latest Patents

Milad's latest patents include the use of the angiotensin-(1-9) peptide or its derivatives for preparing medicaments aimed at preventing, reverting, inhibiting, and/or reducing hypertension. This invention also encompasses a vector that overexpresses the ACE2 enzyme, which is crucial for elevating the concentration of angiotensin-(1-9) in the blood and tissues. The vector may be an adenovirus, retrovirus, lentivirus, or adeno-associated virus containing the gene encoding for ACE2. Furthermore, his inventions allow for the administration of angiotensin-(1-9) in various forms, including oral, injectable, or through continuous infusion pumps. Additionally, he has developed pharmaceutical compositions that include angiotensin-(1-9) and are useful for treating cardiovascular, pulmonary, cerebral, and renal remodeling.

Career Highlights

Milad has worked with esteemed institutions such as Universidad de Chile and Pontificia Universidad Católica de Chile. His research and innovations have positioned him as a key figure in the medical community, particularly in the area of hypertension treatment.

Collaborations

Some of his notable collaborators include Sergio Alejandro Lavandero González and Mario Martin Chiong Lay. Their combined efforts have contributed to advancing research in cardiovascular health.

Conclusion

Jorge Emilio Jalil Milad's innovative work in hypertension treatment showcases the potential of angiotensin-(1-9) and its derivatives in improving cardiovascular health. His contributions continue to influence the medical field and offer hope for effective treatments.